CYTRX CORP
S-1, EX-27.5, 2000-06-21
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CYTRX CORP, S-1, EX-27.4, 2000-06-21
Next: PHOENIX INTERNATIONAL INDUSTRIES INC /FL/, PRER14C, 2000-06-21



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<RESTATED>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                      12,361,398
<SECURITIES>                                         0
<RECEIVABLES>                                  470,017
<ALLOWANCES>                                         0
<INVENTORY>                                      8,308
<CURRENT-ASSETS>                            12,950,070
<PP&E>                                         982,200
<DEPRECIATION>                               (634,169)
<TOTAL-ASSETS>                              13,969,079
<CURRENT-LIABILITIES>                        1,820,178
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         8,256
<OTHER-SE>                                  12,140,645
<TOTAL-LIABILITY-AND-EQUITY>                13,969,079
<SALES>                                         65,730
<TOTAL-REVENUES>                               319,069
<CGS>                                                0
<TOTAL-COSTS>                                   68,540
<OTHER-EXPENSES>                             3,518,237
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (3,267,708)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (3,267,708)
<DISCONTINUED>                                 (8,219)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,275,927)
<EPS-BASIC>                                      (.43)
<EPS-DILUTED>                                    (.43)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission